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Abstract The cellular retinol binding proteins, CRBP and 
CRBP II, are implicated in the cellular uptake of retinol and 
intracellular trafficking of retinol between sites of metabolic 
processing. "F-NMR studies of retinol transfer between CRBP 
and CRBP II and phospholipid vesicles, using either fluorine-
labeled ligand or protein, demonstrated that there was signifi-
cantly more transfer of retinol from CRBP II to lipid vesicles 
than from CRBP. Differences in how readily protein-bound 
retinol is released to lipid bilayers may lead to differences in how 
these two proteins modulate intracellular retinol metabolism. 
Key words: Cellular retinol binding protein; Cellular retinol 
binding protein II; Retinol; Liposome; 19F-NMR 
1. Introduction 
Vitamin A is an essential nutrient required for growth, re-
production, differentiation of epithelial tissues and vision [1]. 
The small intestinal epithelium, esterifies ~ 9 0 % of dietary 
retinol (the alcohol form of vitamin A), and packages the 
retinyl esters into chylomicrons prior to delivery to the liver. 
Most of the retinyl acetate metabolites recovered from the 
intestinal mucosa are in the form of retinyl esters and retinol, 
however, a small fraction is found in the form of retinoic 
acids, retinoyl glucuronides and polar metabolites [2]. Follow-
ing hepatic uptake of chylomicron remnants, the retinol esters 
are hydrolyzed and either complexed with serum retinol bind-
ing protein (RBP) and released to the circulation, or reesteri-
fied with long-chain fatty acids and stored within the liver. 
It has been proposed that specific intracellular carrier pro-
teins participate in the cytoplasmic trafficking of these hydro-
phobic compounds between sites of metabolic processing [3]. 
Cellular retinol binding protein II (CRBP II) is a 15.5 kDa 
intestinal protein that binds all-frani-retinol and all-trans-ret-
inal but not all-írawí-retinoic acid [4]. It is closely homologous 
(sharing 56% amino acid identity) to cellular retinol binding 
protein (CRBP), which is present in many tissues but is par-
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ticularly abundant in liver, kidney and testes [5,6]. The intes-
tinal localization of CRBP II suggests that it is uniquely 
adapted for the intestinal absorption and metabolism of reti-
nol. Both CRBP and CRBP II have been implicated in deliv-
ering retinol to lecithin:retinol acyltransferase based on in 
vitro studies of retinol esterification [7-10]. Overexpression 
of either rat CRBP or rat CRBP II in stably transfected 
Caco-2 cells resulted in increased uptake of retinol and in-
creased esterification of retinol in vivo [11]. The addition of 
apoCRBP has been observed to stimulate hydrolysis of retinyl 
esters in vitro [12-14]. Holo-CRBP complexed with retinol 
serves as the substrate for a microsomal NADP-dependent 
dehydrogenase which converts retinol to retinal [13,15]. Dif-
ferential recognition of the apo- and holo-CRBPs by enzymes 
involved in the metabolism of vitamin A has been proposed as 
a mechanism by which these retinol binding proteins restrict 
the metabolism of the bound retinol to certain metabolic 
pathways, based on analyses of the kinetic parameters ob-
tained when unbound retinol, CRBP-retinol or CRBP II-ret-
inol are used as substrates [7,10,13]. These analyses were made 
with the assumption that both holo-CRBP and holo-CRBP II 
were stable when incubated in the presence of membranes. 
Previous studies measuring transfer of radiolabeled retinol 
or decreases in protein bound retinol fluorescence, indicate 
that little dissociation of the CRBP-retinol complex takes 
place when coincubated with membranes [10,16]. The stability 
of the CRBP II-retinol complex in the presence of membranes 
has not been described thus far. 
We have previously shown that the distribution of retinol 
between CRBP and CRBP II is difficult to predict based on a 
comparison of previously determined dissociation constants 
for these two proteins [17]. This may be due in part to the 
difficulty of accurately measuring dissociation of retinol from 
CRBP and CRBP II in water, given the extremely hydropho-
bic properties of retinol. By fluorometric titration, the disso-
ciation constants for CRBP-retinol and CRBP II-retinol in an 
aqueous buffer have been previously determined to be roughly 
equivalent at 10~8 M [18,19]. Subsequent 19F-NMR studies of 
CRBP and CRBP II isotopically labeled with 6-fluorotrypto-
phan, however, demonstrated that retinol complexed to 
CRBP II is readily transferred to CRBP, whereas retinol com-
plexed to CRBP is not transferred to CRBP II [17]. In con-
trast, retinal is transferred readily in both directions between 
CRBP and CRBP II [17]. These studies suggest that under 
conditions of limiting retinol concentrations CRBP ligand-
binding sites will be preferentially populated over those of 
CRBP II. 
Intracellular retinoid flux also involves movement of reti-
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noids between membranes and the CRBPs. To model the 
distribution of retinol between C R B P and C R B P II and mem-
branes, a fluororetinol analog which exhibits distinct resonan-
ces when complexed to CRBP, C R B P II and when associated 
with lipid vesicles, was used as an 1 9 F - N M R probe to measure 
partitioning of retinol between CRBP, C R B P II and lipid 
vesicles. Transfer of all-frans-retinol between 6-FTrp-CRBP, 
6-FTrp-CRBPII and lipid vesicles was also measured. We re-
port here the results of these studies. 
2. Materials and methods 
2.1. Materials 
6-Fluorotryptophan, deuterium oxide (D2O), all-iraws-retinol and 
cholesterol were purchased from Sigma (St. Louis, MO). Plasmids 
and bacterial strains used for expression of rat CRBP II and rat 
CRBP in E. coli have been described in earlier publications [19-21]. 
Egg lecithin phosphatidylcholine (PC), phosphatidylethanolamine 
(PE) and phosphatidylserine (PS) were purchased from Lipid Products 
Co., UK. 
2.2. Preparation of (all-E)-9-(2-methoxy-6-trifluoromethylphenyl)-
3,7-dimethyl-2,4,6,8-nonatetraen-l-ol (1, Fig. 1) 
The acid derivative of 1 (from Hoffmann-La Roche) was esterified 
with diazomethane and then reduced with diisobutylaluminum hy-
dride to 1 using the procedure reported previously [22]. Ligand 1 
was characterized by NMR spectroscopy. 'H-NMR (CDC13) 7.27 
(2H,m), 7.08 (1H, d, 7=16 Hz), 7.07 (1H, d, 7=10 Hz), 7.01 (1H, 
dd, 7= 15, 11 Hz), 6.78 (1H, dd, / = 16, 1.5 Hz), 6.33 (1H, d, J= 15 
Hz), 6.29 (1H, d, 7=11 Hz), 5.79 (1H, s), 3.88 (3H, s), 3.70 (1H, s), 
2.35 (3H, d, 7= 1.5 Hz), 2.06 (3H, s) ppm from trimefhylsilane (TMS). 
19F-NMR (CDCI3), 14.38 (s) ppm relative to trifluoroacetic acid 
(TFA). 
2.3. Phospholipid vesicle preparation 
Small sonicated PC vesicles were prepared from co-dried lipids as 
previously described [23], except a D2O buffer containing 10 mM 
potassium phosphate pH 7.4, 5 mM 2-mercaptoethanol and 0.05% 
sodium azide was employed. The concentration of phospholipid in 
the stock vesicle preparation was measured by measuring total phos-
phate, and correcting for inorganic phosphate, as described by Ames 
[24]. 
2.4. Production of rat CRBP II and CRBP in E. coli 
Unlabeled rat apoCRBP and apoCRBP II were expressed in E. coli 
strain JM101 harboring the appropriate recombinant expression vec-
tors as described previously [19,20]. 6-Fluorotryptophan was incorpo-
rated into the E. coli tryptophan auxotroph, W3110 trpA33 [25] by 
inducing expression of recombinant protein in media containing the 
analog and purified as described previously [17,21]. 
2.5. NMR measurements 
0.5 ml samples containing holo-CRBP I or holo CRBP II (final 
concentration of 0.2 mM) in 10 mM potassium phosphate, pH 7.4, 
5 mM 2-mercaptoethanol, and 0.05% sodium azide were mixed with 
varying amounts of vesicles. "F-NMR spectra were recorded at 470.3 
MHz without proton decoupling on a Varían VXR-500 (Varían As-
sociates, Palo Alto, CA) spectrometer after mixing (~5-10 min) and 
24-48 h after mixing. The chemical shift was referenced to an internal 
standard (potassium salt of trifluoroacetic acid in solution). All stud-
ies were conducted at 37°C. The T\ values for 1 complexed with 
CRBP II, CRBP and PC liposome were 0.31, 0.29 and 0.36 s, respec-
tively, as measured by inversion-recovery experiments. A delay of 1.5 
s between successive transients was employed to ensure complete re-
laxation and thus quantitation of 19F signals. The integrated inten-
sities of the F resonances were used to measure the relative mole 
quantities of vesicle-bound ligand 1 and of protein-bound ligand 1. 
Measurement of the net transfer of ligand 1 from the CRBPs to the 
PC vesicles represent the average of two separate experiments, using 
two preparations of phospholipid vesicles and of protein. The meas-
urements of the net transfer of retinol from 6-FTrp-labeled CRBPs 
each represent a single NMR experiment. 
3. Results 
3.1. 19F-NMR spectra of ligand 1 complexed with CRBP II, 
CRBP and PC vesicles (see Fig. 2) 
Ligand 1 is a fluororetinol analog (see Fig. 1) that binds 
C R B P and C R B P II with a stoichiometry of 1:1 with appar-
ent dissociation constants that are < 10~8M as determined by 
fluorometric titration. The F resonance corresponding to li-
gand 1 exhibited distinct chemical shifts when associated with 
PC vesicles (16.6 ppm from T F A , see Fig. 2A,B), complexed 
with C R B P II (17.1 ppm from T F A , see Fig. 2C) and com-
plexed with C R B P (19.6 ppm from T F A , see Fig. 2D). Ad-
vantages of using a fluorine probe include both increased 
sensitivity of this nucleus and absence of background signal 
due to natural abundance of the isotope. The 1 9 F - N M R spec-
tra of C R B P II and C R B P complexed with one equivalent of 
ligand 1, and then mixed with increasing amounts of PC 
phospholipid vesicles are shown in Fig. 2 E - H . The relative 
distribution of 1 between the proteins and vesicles was calcu-
lated from the integrated areas under the resonances at 19.6 
ppm (corresponding to 1 complexed with CRBP), 17.1 ppm 
(corresponding to 1 complexed with C R B P II), and 16.6 ppm 
(corresponding to 1 associated with phospholipid vesicles). At 
a protein to phospholipid molar ratio of 1:5, 22 ± 4 % 
( m e a n t S . D . ) of ligand 1 originally bound to CRBPII parti-
tioned to phospholipid vesicles (see Fig. 2E), but there was no 
detectable transfer of 1 from C R B P to phospholipid vesicles 
(see Fig. 2F). At a protein to phospholipid molar ratio of 
1:50, 62 ± 3% of ligand 1 originally bound to C R B P II parti-
tioned into phospholipid vesicles (see Fig. 2G), and only 
6 ± 6 % of ligand 1 originally bound to C R B P partitioned 
into phospholipid vesicles (see Fig. 2H). The relative distribu-
tion of 1 between protein and vesicles in spectra (data not 
shown) representing the initial 16 transients accumulated, ob-
tained approx. 5 min after mixing, is the same as the distri-
bution observed in spectra shown in Fig. 2 ( ~ 1^1 h after 
mixing) as well as that observed in spectra obtained 24-48 h 
after mixing (data not shown). 
3.2. Net transfer of all-trans-retinol between 6-FTrp-CRBP II 
and 6-FTrp-CRBP and phospholipid vesicles 
Isotopic labeling of C R B P and C R B P II with 6-fluorotryp-
all-trans-retinol 
Fig. 1. Structures of all-trans-retinol and its analog. 
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Fig. 2. 19F-NMR spectra of ligand 1 and CRBP, CRBP II and PC vesicles. The un-decoupled 470.3-MHz 19F-NMR spectra were collected as 
described under Section 2. Chemical shifts are referenced to the 19F signal for TFA. 20 Hz line broadening was applied for all spectra, 400-
6000 transients were accumulated for all spectra. (A,B) 0.2 mM 1+50 mM PC; (C) 0.2 mM holo-CRBPII-1; (D) 0.2 mM holo CRBP-1; (E) 
0.2 mM holo CRBP II-l+l mM PC; (F) 0.2 mM holo CRBP-1+1 mM PC; (G) 0.2 mM holo-CRBP II-1+10 mM PC; (H) 0.2 mM holo 
CRBP-1+10 mM PC. 
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Fig. 3. "F-NMR spectra of 6-FTrp-labeled holo-CRBP II and 6-FTrp-labeled holo-CRBP complexed with all-íra«í-retinol after the addition of 
PC liposomes. Varying amounts of PC vesicles were added to 6-FTrp-holo-CRBP and 6-FTrp-holo-CRBP II complexed with all-?raws-retinol. 
470.3 MHz 19F-NMR spectra of (A) 0.2 mM apo-6-FTrp-CRBP II+l mM PC; (B) 0.2 mM apo 6-FTrp-CRBP+1 mM PC; (C) 0.2 mM holo 
6-FTrp-CRBPII; (D) 0.2 mM holo 6-FTrp-CRBP; (E) 0.2 mM holo 6-FTrp-CRBPII+l.O mM PC; (F) 0.2 mM holo 6-FTrp-CRBP+l mM 
PC; (G) 0.2 mM holo-6-FTrp-CRBP 11+10 mM PC. (H) 0.2 mM holo 6-FTrp-CRBP+10 mM PC. Chemical shifts are referenced to the 19F 
signal for TFA. 20 Hz line broadening was applied for all spectra. 400-6000 transients were accumulated for all spectra. The numbers indicate 
the resonance assignments for the four tryptophan residues. 
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tophan, provides residue specific NMR probes for the four 
tryptophan residues at positions 9, 89, 107 and 110 [17]. 
The addition of phospholipid vesicles to 6-FTrp-apoCRBP 
II and 6-FTrp-apoCRBP at a protein to phospholipid molar 
ratio of 1:5 resulted in a slight line broadening (6 Hz) of the F 
resonances but did not significantly perturb the chemical 
shifts. Further addition of vesicles resulted in further broad-
ening (10-20 Hz) (data not shown). 
The F resonances corresponding to Trp9 and Trp107 under-
go ligand-dependent perturbations in chemical shifts when 6-
FTrp-CRBP and 6-FTrp-CRBP II bind all-ira/w-retinol [17]. 
The F resonances corresponding to the Trp89 and Trp110 are 
not perturbed by the addition of all-ircwzs-retinol. We have 
previously shown that the 'doublet' appearance of some of 
the tryptophan resonances is due to the presence of protein 
retaining the initiator methionine and protein in which this 
residue has been removed [21]. The transfer of all-?ra«i-retinol 
from the CRBPs to phospholipid vesicles was monitored by 
measuring the conversion of 6-FTrp-holoCRBPs to 6-FTrp-
apoCRBPs after the addition of phospholipid vesicles. The 
fraction of 6-FTrp-CRBPII which was occupied by ligand 
was calculated from the integrated area under the Trp107 F 
resonance at —43.3 ppm, which corresponds to only the holo-
form of 6-FTrp-CRBP II, relative to the integrated area under 
the Trp110 F resonance at —47.8 ppm, which corresponds to 
both the apo and holo form of 6-FTrp-CRBP II (see Fig. 
3A,C,E,G,I). At a protein to phospholipid molar ratio of 
1:5, 40% of the all-iraws-retinol partitioned away from 6-
FTrp-CRBP II (see Fig. 3E). At a protein to phospholipid 
molar ratio of 1:50, 65% of the all-ftww-retinol partitioned 
away from 6-FTrp-CRBP II (see Fig. 3G). At a 6-FTrp-
CRBP to phospholipid molar ratio of 1:50, 19F-NMR spectra 
(see Fig. 3H) remained virtually identical to that of the hol-
oprotein, indicating that there was minimal transfer of all-
/rans-retinol from CRBP to the lipid vesicles. The studies of 
all-íraní-retinol partitioning between 6-FTrp-CRBP II and 6-
FTrp-CRBP and phospholipid vesicles, thus yielded similar 
results to the studies on the partitioning of the fluororetinol 
analogs between the unlabeled proteins and PC vesicles. 
4. Discussion 
In these 19F-NMR studies the net transfer of protein bound 
retinol to model membranes can be directly observed without 
separation of donor and acceptor complexes. This approach is 
similar to previously described experiments using 13C-NMR 
to measure partitioning of 13C-enriched oleic acid between 
liver fatty acid binding protein (FABP) and unilamellar PC 
vesicles [26] and between albumin and unilamellar PC vesicles 
[27], but has the advantage of utilizing the fluorine nucleus 
which can be detected with higher sensitivity. These 19F-NMR 
studies demonstrate a marked difference in the net transfer of 
protein-bound retinol when complexed with CRBP as op-
posed to CRBP II from phospholipid vesicles. The observa-
tion that holo-CRBP was stable when incubated in the pres-
ence of phospholipid vesicles is consistent with previous 
studies where virtually no decrease in retinol fluorescence 
upon excitation of CRBP was observed when holo-CRBP 
was incubated with membranes [10], and transfer of only 
10% of radiolabeled retinol from holo-CRBP to membranes 
was measured [16]. In contrast there was significantly more 
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dissociation of holo-CRBP II when incubated in the presence 
of phospholipid vesicles. 
Because of the relatively long time (5 min to collect the 
initial 6-16 transients) required to obtain NMR spectra with 
good signal to noise, the kinetics of transfer could not be 
analyzed. The observation that the resonances for ligand 1 
exhibit the same chemical shift in mixtures of protein with 
vesicles as in the isolated systems indicate that exchange is 
slow on the NMR time scale ( < 500 s_1 for exchange of 
ligand 1 between CRBP II and PC vesicles and < 3000 s_ 1 
for exchange between CRBP and PC vesicles). 
The precise functional roles for CRBP and CRBP II remain 
to be defined. It has been proposed that these proteins play a 
role in cellular uptake of retinol, cytoprotection, and modu-
lation of intracellular retinol metabolism [5,11]. These NMR 
studies suggest that CRBP will be more effective than CRBP 
II in serving a cytoprotective function. Since bound retinol is 
oriented within the binding pockets of both CRBP and CRBP 
II with the alcohol moiety situated innermost, this alcohol 
moiety of bound retinol is not immediately accessible for 
modification [5]. Differences in how readily retinol is released 
from the binding pocket to lipid bilayers may lead to differ-
ences in how CRBP-retinol and CRBP-II retinol interact with 
various sites of metabolic processing within the cell. 
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